2023 Guideline for the Management of Hypertension in the Elderly Population in China

Overview

Journal J Geriatr Cardiol

Specialty Geriatrics

Date 2024 Jul 8

PMID 38973827

Authors

Qi Hua

Li Fan

Zeng-Wu Wang

Jing Li

Affiliations

Soon will be listed here.

References

Kwon S, Thompson R, Florence M, Maier R, McIntyre L, Rogers T . β-blocker continuation after noncardiac surgery: a report from the surgical care and outcomes assessment program. Arch Surg. 2012; 147(5):467-73. PMC: 4211634. DOI: 10.1001/archsurg.2011.1698. View

Borer J, Deedwania P, Kim J, Bohm M . Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease. Am J Cardiol. 2016; 118(12):1948-1953. DOI: 10.1016/j.amjcard.2016.08.089. View

Dong L, Yan H, Wang D . Polypharmacy and its correlates in village health clinics across 10 provinces of Western China. J Epidemiol Community Health. 2009; 64(6):549-53. DOI: 10.1136/jech.2008.085415. View

ORourke M, Namasivayam M, Adji A . Treatment of hypertension in patients 80 years of age or older. Minerva Med. 2009; 100(1):25-38. View

Xiong C, Yang B . Revising the hemodynamic criteria for pulmonary hypertension: A perspective from China. J Transl Int Med. 2023; 11(1):1-3. PMC: 10202014. DOI: 10.2478/jtim-2022-0023. View

Li T, Wang H, Yang Y, Galvin J, Morris J, Yu X . [The reliability and validity of Chinese version of AD8]. Zhonghua Nei Ke Za Zhi. 2013; 51(10):777-80. View

Haywood L, Ford C, Crow R, Davis B, Massie B, Einhorn P . Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). J Am Coll Cardiol. 2009; 54(22):2023-31. DOI: 10.1016/j.jacc.2009.08.020. View

Friberg L, Rosenqvist M, Lip G . Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012; 33(12):1500-10. DOI: 10.1093/eurheartj/ehr488. View

Feldman R, Zou G, Vandervoort M, Wong C, Nelson S, Feagan B . A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension. 2009; 53(4):646-53. DOI: 10.1161/HYPERTENSIONAHA.108.123455. View

10.

Wright Jr J, Fine L, Lackland D, Ogedegbe G, Himmelfarb C . Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view. Ann Intern Med. 2014; 160(7):499-503. DOI: 10.7326/M13-2981. View

11.

Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Back M . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34):3227-3337. DOI: 10.1093/eurheartj/ehab484. View

12.

Clegg A, Young J, Iliffe S, Rikkert M, Rockwood K . Frailty in elderly people. Lancet. 2013; 381(9868):752-62. PMC: 4098658. DOI: 10.1016/S0140-6736(12)62167-9. View

13.

Mancia G, Facchetti R, Bombelli M, Cuspidi C, Grassi G . White-Coat Hypertension: Pathophysiological and Clinical Aspects: Excellence Award for Hypertension Research 2020. Hypertension. 2021; 78(6):1677-1688. PMC: 9634724. DOI: 10.1161/HYPERTENSIONAHA.121.16489. View

14.

Arima H, Chalmers J, Woodward M, Anderson C, Rodgers A, Davis S . Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens. 2006; 24(6):1201-8. DOI: 10.1097/01.hjh.0000226212.34055.86. View

15.

Wang H, Li Y, Chai K, Zhang W, Li X, Dong Y . [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China]. Zhonghua Xin Xue Guan Bing Za Zhi. 2019; 47(11):865-874. DOI: 10.3760/cma.j.issn.0253-3758.2019.11.004. View

16.

Anderson C, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C . Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013; 368(25):2355-65. DOI: 10.1056/NEJMoa1214609. View

17.

Cohn J, Ziesche S, Smith R, Anand I, Dunkman W, LOEB H . Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group. Circulation. 1997; 96(3):856-63. DOI: 10.1161/01.cir.96.3.856. View

18.

Staessen J, Fagard R, Thijs L, Celis H, Arabidze G, Birkenhager W . Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997; 350(9080):757-64. DOI: 10.1016/s0140-6736(97)05381-6. View

19.

Bhm M, Anker S, Mahfoud F, Lauder L, Filippatos G, Ferreira J . Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. Eur Heart J. 2022; 44(5):396-407. PMC: 9890225. DOI: 10.1093/eurheartj/ehac693. View

20.

Ambrosius W, Sink K, Foy C, Berlowitz D, Cheung A, Cushman W . The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014; 11(5):532-46. PMC: 4156910. DOI: 10.1177/1740774514537404. View